Holen Sie sich die Stockscreener-App
36.74
0.14%
0.05
Schlusskurs vom Vortag:
$36.69
Offen:
$36.62
24-Stunden-Volumen:
724.73K
Relative Volume:
1.38
Marktkapitalisierung:
$1.19B
Einnahmen:
Nettoeinkommen (Verlust:
$-38.95M
KGV:
-24.73
EPS:
-1.4857
Netto-Cashflow:
$-50.43M
1W Leistung:
-1.29%
1M Leistung:
-13.70%
6M Leistung:
+29.92%
1J Leistung:
+124.02%
1-Tages-Spanne:
$36.06
$37.37
1-Wochen-Bereich:
$33.88
$37.43
52-Wochen-Spanne:
$14.32
$50.16
Lb Pharmaceuticals Inc Stock (LBRX) Company Profile
Firmenname
Lb Pharmaceuticals Inc
Sektor
Branche
Telefon
917-450-6581
Adresse
575 MADISON AVENUE, NEW YORK
Compare LBRX vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LBRX
Lb Pharmaceuticals Inc
|
36.74 | 1.19B | 0 | -38.95M | -50.43M | -1.4857 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Lb Pharmaceuticals Inc Stock (LBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2026-10-06 | Eingeleitet | Guggenheim | Buy |
| 2026-10-05 | Herabstufung | Roth Capital | Buy → Neutral |
| 2026-10-02 | Eingeleitet | Needham | Buy |
| 2026-07-21 | Eingeleitet | BMO Capital Markets | Outperform |
| 2026-07-07 | Eingeleitet | Wolfe Research | Outperform |
| 2026-04-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2026-04-10 | Eingeleitet | Craig Hallum | Buy |
| 2026-01-09 | Eingeleitet | Roth Capital | Buy |
| 2025-10-06 | Eingeleitet | Leerink Partners | Outperform |
| 2025-10-06 | Eingeleitet | Piper Sandler | Overweight |
| 2025-10-06 | Eingeleitet | Stifel | Buy |
Alle ansehen
Lb Pharmaceuticals Inc Aktie (LBRX) Neueste Nachrichten
LB Pharmaceuticals Grants Inducement Equity Awards to New Chief Medical Officer and Chief Financial Officer - Quiver Quantitative
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
Can LB Pharmaceuticals (NASDAQ:LBRX) Keep Its Fresh Rebound Going Strong? - Kalkine Media
LB Pharmaceuticals (NASDAQ:LBRX) Shares Climb 4.7%Should You Buy? - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 5.4% Following Analyst Downgrade - MarketBeat
Needham initiates LB Pharmaceuticals stock with buy rating - Investing.com
Apnimed gives 19 new hires the right to buy 481,300 shares - Stock Titan
LB Pharmaceuticals Inc (LBRX) Stock Price & News - Syfe
LB Pharmaceuticals Inc (NASDAQ:LBRX) Stock Rated "Moderate Buy" by Sell-Side Analysts - MarketBeat
LBRX: LB Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
LB Pharmaceuticals (Nasdaq:LBRX)Stock Analysis - Simply Wall Street
LB Pharmaceuticals (NasdaqGM:LBRX) Stock Price - Simply Wall Street
LB Pharmaceuticals Inc (LBRX) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
LB Pharmaceuticals Names Dr. Susan Kozauer as Chief Medical Officer with Detailed Compensation Package - Kalkine Media
Form 8K LB Pharmaceuticals Inc For: 15 September By Investing.com - Investing.com India
A doctor who helped develop an FDA-approved psychiatric drug joins LB Pharmaceuticals - Stock Titan
LB Pharmaceuticals (LBRX) CFO reports zero share ownership - Stock Titan
Bank of America Corp DE Has $410,000 Stock Position in LB Pharmaceuticals Inc $LBRX - MarketBeat
Bank of New York Mellon Corp Makes New $1.78 Million Investment in LB Pharmaceuticals Inc $LBRX - MarketBeat
LB Pharmaceuticals (NASDAQ: LBRX) Names Joseph M. Miller as CFO with $530K Salary and 200,000-Share Stock Option - Kalkine Media
2 Reasons LB Pharmaceuticals (LBRX) Looks Pricey Following Its CFO Appointment - Yahoo Finance
LB Pharmaceuticals to Participate in Upcoming September Investor Events - GlobeNewswire
LB Pharmaceuticals Names Joseph M. Miller as CFO, Details Compensation and Severance Package - kalkinemedia.com
LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 4.3%Here's What Happened - MarketBeat
LB Pharmaceuticals (NASDAQ: LBRX) Appoints Joseph M. Miller as CFO with $530K Salary and Equity Incentives - kalkinemedia.com
LB Pharmaceuticals Inc Announces Appointment of Joseph M. Miller to Chief Financial Officer, Effective September 2, 2026 - marketscreener.com
LB Pharmaceuticals Appoints Joseph Miller as New CFO - TipRanks
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer - The Manila Times
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer - marketscreener.com
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer - Yahoo Finance
LB Pharmaceuticals (LBRX) Edges Lower to $47.14 as Support HoldsShakeout Pattern - siam.in
Four new hires get rights to buy 269,000 Zentalis shares - Stock Titan
LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
HC Wainwright Issues Pessimistic Forecast for LBRX Earnings - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Sets New 52-Week High After Analyst Upgrade - MarketBeat
H.C. Wainwright raises LB Pharmaceuticals price target to $60 By Investing.com - Investing.com India
H.C. Wainwright raises LB Pharmaceuticals price target to $60 By Investing.com - Investing.com Canada
HC Wainwright Forecasts Strong Price Appreciation for LB Pharmaceuticals (NASDAQ:LBRX) Stock - MarketBeat
Great Lakes Advisors LLC Purchases Shares of 30,410 LB Pharmaceuticals Inc $LBRX - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Sets New 12-Month HighTime to Buy? - MarketBeat
LB (LBRX) Technical Check: Climbs 1.88% to $47.10 on the Day; Level Position: the $44.74 to $49.46 Range Remains in FocusPositive Gamma - vinanet.vn
LB Pharmaceuticals (NASDAQ:LBRX) Cut to Sell at Wall Street Zen - marketbeat.com
LB Pharmaceuticals (LBRX) investor group reports 5.0% beneficial stake in 13G/A - Stock Titan
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook By Investing.com - Investing.com South Africa
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook By Investing.com - Investing.com South Africa
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook - Investing.com
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook By Investing.com - Investing.com Nigeria
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook By Investing.com - Investing.com Canada
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook By Investing.com - Investing.com India
Finanzdaten der Lb Pharmaceuticals Inc-Aktie (LBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):